Found: 22
Select item for more details and to access through your institution.
Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance.
- Published in:
- Wiener Klinische Wochenschrift, 2015, v. 127, n. 9/10, p. 337, doi. 10.1007/s00508-014-0674-6
- By:
- Publication type:
- Article
Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Matrix Metalloproteinase-9 and the Cu/Zn Ratio as Ancillary Diagnostic Tools in Distinguishing Between the Classical and Follicular Variants of Papillary Thyroid Carcinoma.
- Published in:
- Biological Trace Element Research, 2012, v. 149, n. 1, p. 29, doi. 10.1007/s12011-012-9404-y
- By:
- Publication type:
- Article
Thyroid peroxidase immunohistochemistry in differential diagnosis of thyroid tumors.
- Published in:
- Endocrine Pathology, 2006, v. 17, n. 1, p. 53, doi. 10.1385/EP:17:1:53
- By:
- Publication type:
- Article
Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.
- Published in:
- International Journal of Experimental Pathology, 2018, v. 99, n. 2, p. 87, doi. 10.1111/iep.12268
- By:
- Publication type:
- Article
Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration.
- Published in:
- Croatian Medical Journal, 2014, v. 55, n. 2, p. 128, doi. 10.3325/cmj.2014.55.128
- By:
- Publication type:
- Article
Caveolin-1 Expression in Papillary Thyroid Carcinoma: Correlation with Clinicopathological Parameters and BRAF Mutation Status.
- Published in:
- Otolaryngology-Head & Neck Surgery, 2014, v. 150, n. 2, p. 201, doi. 10.1177/0194599813512781
- By:
- Publication type:
- Article
Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients.
- Published in:
- Journal of Clinical Laboratory Analysis, 2009, v. 23, n. 5, p. 341, doi. 10.1002/jcla.20339
- By:
- Publication type:
- Article
Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 12, p. 1805, doi. 10.1007/s00432-010-0838-3
- By:
- Publication type:
- Article
Cytokeratin19 expression discriminates papillary thyroid carcinoma from other thyroid lesions and predicts its aggressive behavior.
- Published in:
- Medical Oncology, 2013, v. 30, n. 1, p. 1, doi. 10.1007/s12032-012-0362-1
- By:
- Publication type:
- Article
MEASURING THYROGLOBULIN CONCENTRATIONS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA.
- Published in:
- Journal of Medical Biochemistry, 2010, v. 29, n. 4, p. 245, doi. 10.2478/v10011-010-0029-4
- By:
- Publication type:
- Article
Galectin-3 expression in papillary thyroid carcinoma: Relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size.
- Published in:
- Head & Neck, 2005, v. 27, n. 12, p. 1049, doi. 10.1002/hed.20276
- By:
- Publication type:
- Article
Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
- Published in:
- Cancer Cytopathology, 2015, v. 123, n. 8, p. 471, doi. 10.1002/cncy.21554
- By:
- Publication type:
- Article
Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.
- Published in:
- APMIS, 2016, v. 124, n. 4, p. 271, doi. 10.1111/apm.12505
- By:
- Publication type:
- Article
Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.
- Published in:
- APMIS, 2012, v. 120, n. 5, p. 368, doi. 10.1111/j.1600-0463.2011.02842.x
- By:
- Publication type:
- Article
Caveolin-1 expression in thyroid neoplasia spectrum: Comparison of two commercial antibodies.
- Published in:
- Disease Markers, 2012, v. 33, n. 6, p. 321, doi. 10.1155/2012/741676
- By:
- Publication type:
- Article
IMUNOHISTOHEMIJSKA ANALIZA TIREOIDNE PEROKSIDAZE, GALEKTINA-3, HBME-1 I CITOKERATINA 19 U TUMORIMA ŠTITASTE ŽLEZDE: DIJAGNOSTIČKI I PROGNOSTIČKI ZNAČAJ.
- Published in:
- Medical Gazette / Medicinski Glasnik, 2012, v. 17, n. 44S, p. 85
- By:
- Publication type:
- Article
Strong Expression of HBME-1 Associates with High-Risk Clinicopathological Factors of Papillary Thyroid Carcinoma.
- Published in:
- Pathology & Oncology Research, 2015, v. 21, n. 3, p. 735, doi. 10.1007/s12253-014-9883-6
- By:
- Publication type:
- Article
Coexistence of BRAFV600E mutation and EGFR overexpression is highly associated with adverse clinicopathological features of papillary thyroid carcinoma.
- Published in:
- Archives of Biological Sciences, 2020, v. 72, n. 1, p. 37, doi. 10.2298/ABS190920064P
- By:
- Publication type:
- Article
Enhanced acid protease activity of lysosomes from papillary thyroid carcinoma.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature.
- Published in:
- Diagnostic Pathology, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13000-015-0428-4
- By:
- Publication type:
- Article